{"id":"https://openalex.org/W4286560191","doi":"https://doi.org/10.3389/fonc.2022.885139","title":"The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer","display_name":"The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-22","ids":{"openalex":"https://openalex.org/W4286560191","doi":"https://doi.org/10.3389/fonc.2022.885139","pmid":"https://pubmed.ncbi.nlm.nih.gov/35936728","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9354847"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.885139","doi":"https://doi.org/10.3389/fonc.2022.885139","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.885139","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4286560191"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2022.885139","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100433724","display_name":"Yu Zhang","orcid":"https://orcid.org/0000-0003-3120-9678","observed_orcids":["https://orcid.org/0000-0003-3120-9678"]},"institutions":[{"id":"https://openalex.org/I131434179","display_name":"Nanjing University of Chinese Medicine","ror":"https://ror.org/04523zj19","country_code":"CN","type":"education","lineage":["https://openalex.org/I131434179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Zhang","raw_affiliation_strings":["Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, China","institution_ids":["https://openalex.org/I131434179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043672686","display_name":"Shukui Qin","orcid":"https://orcid.org/0000-0003-2289-1521","observed_orcids":["https://orcid.org/0000-0003-2289-1521"]},"institutions":[{"id":"https://openalex.org/I4210118317","display_name":"81th Hospital of PLA","ror":"https://ror.org/02xxx6w64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210118317"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Shukui Qin","raw_affiliation_strings":["Department of Medical Oncology Center, BaYi Affiliated Hospital, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology Center, BaYi Affiliated Hospital, Nanjing, China","institution_ids":["https://openalex.org/I4210118317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046991229","display_name":"Jiaojiao Chao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I131434179","display_name":"Nanjing University of Chinese Medicine","ror":"https://ror.org/04523zj19","country_code":"CN","type":"education","lineage":["https://openalex.org/I131434179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiaojiao Chao","raw_affiliation_strings":["Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing, China","institution_ids":["https://openalex.org/I131434179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034395433","display_name":"Yan Luo","orcid":"https://orcid.org/0000-0003-0431-3162","observed_orcids":["https://orcid.org/0000-0003-0431-3162"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan Luo","raw_affiliation_strings":["Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education (MOE)), Zhejiang University School of Medicine, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education (MOE)), Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016871790","display_name":"Yandi Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yandi Sun","raw_affiliation_strings":["Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education (MOE)), Zhejiang University School of Medicine, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Cancer Institute of the Second Affiliated Hospital (Key Laboratory of Cancer Prevention and Intervention of China National Ministry of Education (MOE)), Zhejiang University School of Medicine, Hangzhou, China","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]}]},{"author_position":"last","author":{"id":null,"display_name":"Jianxin Duan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianxin Duan","raw_affiliation_strings":["Ascentawits Pharmaceuticals, Ltd., Shenzhen, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ascentawits Pharmaceuticals, Ltd., Shenzhen, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5043672686"],"corresponding_institution_ids":["https://openalex.org/I4210118317"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.6935,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.63242277,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"12","issue":null,"first_page":"885139","last_page":"885139"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.8690000176429749},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6069999933242798},{"id":"https://openalex.org/keywords/akr1c3","display_name":"AKR1C3","score":0.8980000019073486},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7229999899864197},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8050000071525574},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.7839999794960022},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7770000100135803},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.6100000143051147},{"id":"https://openalex.org/keywords/apatinib","display_name":"apatinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.45500001311302185},{"id":"https://openalex.org/keywords/primary-liver-cancer","display_name":"primary liver cancer","score":0.5709999799728394},{"id":"https://openalex.org/keywords/hepg2-cells","display_name":"HepG2 cells","score":0.7639999985694885},{"id":"https://openalex.org/keywords/plc-prf-5-cells","display_name":"PLC/PRF/5 cells","score":0.9459999799728394}],"concepts":[{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.9402530193328857},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7666944265365601},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.7631703615188599},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5649276971817017},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5416607856750488},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4898664653301239},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.489764928817749},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4685583710670471},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4045619070529938},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38469406962394714},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13692814111709595},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08351927995681763}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2022.885139","doi":"https://doi.org/10.3389/fonc.2022.885139","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.885139","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9354847","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9354847/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9354847/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:35936728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35936728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f03ed761c71f4012808fa22ccdf0beb8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f03ed761c71f4012808fa22ccdf0beb8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.885139","doi":"https://doi.org/10.3389/fonc.2022.885139","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.885139","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4286560191.pdf","grobid_xml":"https://content.openalex.org/works/W4286560191.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W333342186","https://openalex.org/W1569419363","https://openalex.org/W1596503641","https://openalex.org/W1965309017","https://openalex.org/W1974329403","https://openalex.org/W1980586896","https://openalex.org/W2007334137","https://openalex.org/W2015357862","https://openalex.org/W2027860197","https://openalex.org/W2077189182","https://openalex.org/W2077680152","https://openalex.org/W2098193929","https://openalex.org/W2101459399","https://openalex.org/W2118385994","https://openalex.org/W2172020436","https://openalex.org/W2539520833","https://openalex.org/W2591750377","https://openalex.org/W2621094496","https://openalex.org/W2810381975","https://openalex.org/W2898609957","https://openalex.org/W2907978256","https://openalex.org/W2923882329","https://openalex.org/W2940843937","https://openalex.org/W2947951060","https://openalex.org/W3010944796","https://openalex.org/W3013074910","https://openalex.org/W3128646645","https://openalex.org/W3129138489","https://openalex.org/W3175402831"],"related_works":["https://openalex.org/W4361853947","https://openalex.org/W1969888716","https://openalex.org/W4318590084","https://openalex.org/W2913157470","https://openalex.org/W2501032850","https://openalex.org/W4408951425","https://openalex.org/W2026546029","https://openalex.org/W2138929977","https://openalex.org/W130029957","https://openalex.org/W2284106558"],"abstract_inverted_index":{"Background":[0],"Primary":[1],"liver":[2,33,42],"cancer":[3,34],"(PLC)":[4],"is":[5,19,35,55,58,60,64,69,82],"a":[6,83,86,115,398],"common":[7],"and":[8,23,37,50,66,97,102,113,137,142,178,201,206,212,238,272,281,306,340,349,384,391,408,419],"highly":[9],"lethal":[10],"malignancy":[11,54],"in":[12,104,110,234,275,299,320,343,379,397],"the":[13,51,67,92,105,108,111,133,171,191,291,300,308,315,331,344,365,368,392,403],"world.":[14],"Approximately":[15],"85%":[16],"of":[17,32,53,85,100,107,118,127,139,164,184,198,230,262,293,310,318,333,346,367],"PLC":[18],"hepatocellular":[20],"carcinoma":[21],"(HCC),":[22],"this":[24,128],"study":[25,129],"mainly":[26],"focuses":[27],"on":[28],"HCC.":[29],"The":[30,125,194,216,227,260,373],"onset":[31],"insidious":[36],"often":[38],"complicated":[39],"with":[40,121,145,204,284,322,352,364,381,394,402],"basic":[41],"disease.":[43],"Meanwhile,":[44],"its":[45,62,75,79,95,358,416],"clinical":[46],"symptoms":[47],"are":[48,411],"atypical,":[49],"degree":[52],"high.":[56],"What":[57],"worse":[59],"that":[61,357,377],"treatment":[63],"difficult,":[65],"prognosis":[68],"poor.":[70],"All":[71],"these":[72],"factors":[73],"make":[74],"mortality":[76],"close":[77],"to":[78,131,247,413],"incidence.":[80],"AST-3424":[81,140,199,231,251,263,279,319,347,378],"prodrug":[84],"potent":[87],"nitrogen":[88],"mustard,":[89],"which":[90],"targets":[91],"tumor":[93,112],"by":[94,169,189,210,222],"specific":[96],"selective":[98],"mode":[99],"activation":[101],"results":[103],"concentration":[106],"drug":[109],"plays":[114],"higher":[116,245,266],"intensity":[117],"antitumor":[119,135,196,316,359,389,417,423],"effect":[120,317],"reduced":[122],"side":[123],"effects.":[124],"purpose":[126],"was":[130,167,187,208,220,257,264,324],"explore":[132,420],"in-vitro":[134,195,374,404,407],"activity":[136,197],"mechanism":[138,219],"monotherapy":[141,200,280,348],"combination":[143,202,282,321,350,380,393],"therapy":[144,203,283,351],"oxaliplatin":[146],"(OXA)":[147],"or":[148,286,354],"5-fluorouracil":[149],"(5-Fu).":[150],"Moreover,":[151,241],"it":[152],"can":[153],"provide":[154],"an":[155,387],"experimental":[156],"basis":[157],"for":[158],"further":[159,414],"studies.":[160],"Methods":[161],"Tumor":[162,182],"growth":[163,211],"HCC":[165,185,277,294,297,311],"cells":[166,186,237,243,298],"examined":[168,188],"using":[170,190,223],"Cell":[172],"Counting":[173],"Kit-8":[174],"(CCK-8),":[175],"flow":[176],"cytometry,":[177],"clone":[179],"formation":[180],"assays.":[181],"migration":[183,309],"Transwell":[192],"assay.":[193],"OXA":[205,285,323,353,383,395],"5-Fu":[207,287,385],"quantified":[209],"metastasis":[213],"inhibition":[214,261],"rate.":[215],"underlying":[217],"molecular":[218],"investigated":[221],"Western":[224,327],"blotting.":[225],"Results":[226],"inhibiting":[228],"effects":[229,418],"were":[232],"significant":[233],"both":[235,276,382],"HepG2":[236,242],"PLC/PRF/5":[239],"cells.":[240,278,312],"showed":[244,386],"sensitivity":[246],"AST-3424.":[248],"With":[249],"increasing":[250],"concentration,":[252],"AKR1C3":[253],"protein":[254],"expression":[255],"level":[256],"downregulated":[258],"significantly.":[259],"significantly":[265],"than":[267],"OXA,":[268],"5-Fu,":[269,355],"Sor":[270],"(sorafenib),":[271],"Apa":[273],"(apatinib)":[274],"all":[288],"strongly":[289],"inhibited":[290],"proliferation":[292],"cells,":[295],"blocked":[296],"S":[301],"phase,":[302],"promoted":[303],"apoptosis":[304],"induction,":[305],"suppressed":[307],"Among":[313],"them,":[314],"obviously":[325],"enhanced.":[326],"blotting":[328],"analysis":[329],"demonstrated":[330],"regulation":[332,366],"P21,":[334],"Bax,":[335],"Caspase3,":[336],"PARP,":[337],"MMP-2,":[338],"MMP-9,":[339],"p-Smad":[341],"proteins":[342],"presence":[345],"indicating":[356],"mechanisms":[360],"may":[361],"be":[362],"associated":[363],"TGF-\u03b2":[369],"signaling":[370],"cascade.":[371],"Conclusion":[372],"studies":[375,410],"revealed":[376],"increased":[388],"effect,":[390],"resulted":[396],"synergistic":[399],"effect.":[400],"Together":[401],"results,":[405],"additional":[406],"in-vivo":[409],"warranted":[412],"certify":[415],"more":[421],"potential":[422],"mechanisms.":[424]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4286560191","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-07-22T00:00:00"}
